Osteoporosis Post-Fracture — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Alendronate 70 mg weekly
For osteoporosis with fragility fracture, bisphosphonates (alendronate or risedronate) are first-line therapy in Australia. With eGFR >30 mL/min/1.73 m², alendronate is appropriate without dose adjustment. Below eGFR 30, bisphosphonates are generally avoided and denosumab becomes preferred. Teriparatide is PBS-listed for severe osteoporosis with fractures who fail or are intolerant of bisphosphonates. Calcium (1200 mg/day) and vitamin D (800–1000 IU/day) supplementation is essential.
Reference: RACGP – 2017 – Osteoporosis Clinical Guideline; eTG – 2025 – Rheumatology